Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1 clinical trials
Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Ivermectin which is an FDA-approved broad spectrum anti-parasitic agent, has also anti-viral activity. In vitro study have shown its activity against SARS-CoV-2, however its clinical effect on patients with COVID-19 never been tested. In this RCT we would like to evaluate the effect of Ivermectin on reduction of viral shedding …

acute respiratory syndrome (sars)
ivermectin
viral shedding
covid-19
SARS
  • 0 views
  • 19 Feb, 2024